近日,中共中央办公厅、国务院办公厅印发《关于深化审评审批制度改革鼓励药品医疗器械创新的意见》,对此国家食品药品监督管理总局召开新闻发布会,对这份高规格推出、着眼长远制度建设的纲领性文件做出解读。深层次问题的破题之策国家食药监管总局副局长吴浈表示,目前,药品医疗器械研发和质量与国际先进水平仍存在较大差距,支持创新的一些深层次问题还有待解决。一是企业创新能力较弱。国内制药企业数量 Recently, the General Office of the CPC Central Committee and the General Office of the State Council printed and distributed the Opinions on Deepening the Innovation of Examination, Approval and Approval System to Encourage the Innovation of Medical Devices for Medical Devices. In this regard, the State Food and Drug Administration held a press conference to launch this high-specification long- System construction of the programmatic document to interpret. Wu Yong, deputy director of the State Food and Drug Administration said at present, there is still a big gap between the quality of medical device research and development and the international advanced level, and some deep-seated problems in supporting innovation have yet to be solved. First, weaker enterprise innovation ability. Domestic pharmaceutical companies